PRESS RELEASE published on 01/19/2026 at 07:30, 4 months 3 days ago Inside Information / Other news releases FDA accepts Advicenne's Marketing Authorization Application for Sibnayal® for dRTA treatment in the US, with a PDUFA decision target date of September 3rd, 2026 FDA Advicenne Sibnayal DRTA PDUFA
PRESS RELEASE published on 01/19/2026 at 07:30, 4 months 3 days ago Informations privilégiées / Autres communiqués Advicenne annonce l'acceptation de Sibnayal pour examen par la FDA aux Etats-Unis pour le traitement de l’ATRd. Date PDUFA fixée au 3 septembre 2026 FDA Advicenne ATRd Sibnayal PDUFA
BRIEF published on 01/12/2026 at 07:35, 4 months 10 days ago Renewal of the marketing authorization for Sibnayal® in the European Union Kidney Disease EMA Advicenna AMM Sibnayal®
BRIEF published on 01/12/2026 at 07:35, 4 months 10 days ago Renouvellement de l'AMM de Sibnayal® dans l'Union Européenne Advicenne Maladies Rénales EMA AMM Sibnayal®
PRESS RELEASE published on 01/12/2026 at 07:30, 4 months 10 days ago Informations privilégiées / Autres communiqués Advicenne annonce le succès du renouvellement de l’AMM de Sibnayal® dans l’Union Européenne. L'EMA a validé l'autorisation de mise sur le marché, renforçant le développement commercial de Sibnayal® Renouvellement Union Européenne Advicenne AMM Sibnayal
BRIEF published on 11/04/2025 at 11:35, 6 months 18 days ago Advicenne soumet Sibnayal® à la FDA américaine FDA Advicenne Sibnayal® Acidose Tubulaire Rénale Dépôt D'enregistrement
BRIEF published on 11/04/2025 at 11:35, 6 months 18 days ago Advicenne submits Sibnayal® to the US FDA FDA Advicenna Sibnayal® Renal Tubular Acidosis Registration Filing
PRESS RELEASE published on 11/04/2025 at 11:30, 6 months 18 days ago Informations privilégiées / Autres communiqués Advicenne dépose le dossier d'enregistrement de Sibnayal® auprès de la FDA américaine pour le traitement de l'ATRd. Webconférence le 5 novembre 2025. Informations sur ADV7103 et le développement clinique FDA Advicenne Webconférence ATRd Sibnayal
PRESS RELEASE published on 11/04/2025 at 11:30, 6 months 18 days ago Inside Information / Other news releases Advicenne submits registration application for Sibnayal® in dRTA treatment to US FDA, designated orphan drug. Evaluation process expected to take 12 months Advicenne Sibnayal® US FDA DRTA Treatment Registration Application
BRIEF published on 09/19/2025 at 18:05, 8 months 2 days ago Advicenne: Half-year results in 2025 and outlook Financial Results Outlook Turnover United States Sibnayal®
Published on 05/22/2026 at 13:00, 18 minutes ago Galantas Gold Files Management Information Circular in Connection with the Proposed Acquisition of Andacollo Project
Published on 05/22/2026 at 13:00, 18 minutes ago Formation Metals Announces Closing of Upsized $22.4 Million Non-Brokered Private Placement to Increase Drill Program to 75,000 Metres
Published on 05/22/2026 at 08:00, 5 hours 18 minutes ago Caledonia Mining Corporation Plc: Refiling of Bilboes Gold Project Feasibility Study National Instrument 43-101 Technical Report
Published on 05/21/2026 at 23:00, 14 hours 18 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/22/2026 at 12:37, 41 minutes ago EQS-Adhoc: Appointment of new Chief Executive Officer of Carl Zeiss Meditec AG
Published on 05/22/2026 at 12:12, 1 hour 5 minutes ago EQS-Adhoc: Gateway Real Estate AG intends to restructure its bond
Published on 05/22/2026 at 11:33, 1 hour 44 minutes ago Project WAL reserves capacity on GASCADE’s H2 core network
Published on 05/22/2026 at 11:30, 1 hour 48 minutes ago AppliedAI and McKinsey & Company collaborate to rapidly rewire regulated enterprise processes with AI
Published on 05/22/2026 at 11:05, 2 hours 13 minutes ago RITFIT Partners with LA Galaxy's Marco Reus, Redefining High Quality Training at Home and Showcasing the Evolution of Professional Home Gym Ecosystems
Published on 05/22/2026 at 12:52, 25 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 25 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 4 hours 48 minutes ago Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/22/2026 at 08:30, 4 hours 48 minutes ago Eiffage réalise quatre centrales photovoltaïques dans le cadre du programme NOOR Atlas au Maroc
